BioCentury | Oct 5, 2017
Strategy

Fixing FDA’s FAERS

...consortia and non-profit sites -- such as the European Molecular Biology Laboratory ’s (EMBL) ChEMBL, Biobyte Solutions...
...Institutions Mentioned Advera Health Analytics Inc., Santa Rosa, Calif. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Biobyte Solutions...
BioCentury | Jul 31, 2008
Distillery Techniques

This Week in Techniques

...cell-based assays and animal testing. (See Look to the side (effects), page 9.) Method patented; biobyte solutions GmbH...
BioCentury | Jul 31, 2008
Tools & Techniques

Look to the side (effects)

...side effects. Bork told SciBX that the approach has been patented. Ivica Letunic, CEO of biobyte solutions GmbH...
...including side effect-based drug target prediction. Companies and Institutions Mentioned Arachnova Ltd. , Cambridge, U.K. biobyte solutions GmbH...
Items per page:
1 - 3 of 3
BioCentury | Oct 5, 2017
Strategy

Fixing FDA’s FAERS

...consortia and non-profit sites -- such as the European Molecular Biology Laboratory ’s (EMBL) ChEMBL, Biobyte Solutions...
...Institutions Mentioned Advera Health Analytics Inc., Santa Rosa, Calif. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Biobyte Solutions...
BioCentury | Jul 31, 2008
Distillery Techniques

This Week in Techniques

...cell-based assays and animal testing. (See Look to the side (effects), page 9.) Method patented; biobyte solutions GmbH...
BioCentury | Jul 31, 2008
Tools & Techniques

Look to the side (effects)

...side effects. Bork told SciBX that the approach has been patented. Ivica Letunic, CEO of biobyte solutions GmbH...
...including side effect-based drug target prediction. Companies and Institutions Mentioned Arachnova Ltd. , Cambridge, U.K. biobyte solutions GmbH...
Items per page:
1 - 3 of 3